OxThera (Sweden)
Stockholm – 25 February 2021. OxThera AB, a privately-held biopharmaceutical company dedicated to improving the lives of people with Primary Hyperoxaluria (PH), announces that a new US patent has been granted for its product candidate Oxabact announces that a new US patent has been granted for its product candidate Oxabact, and for a method for the treatment or… Kidney Health Initiative (KHI) has the mission to advance scientific understanding of the kidney health and patient safety impli
Basic Information
- Category: business
- Website: http://www.oxthera.com/
Documented Facts
- Email: info.oxthera@oxthera.com (No linked source recorded for this statement.)
Evidence and Sources
- OxThera (Sweden) — Official Site (official)
Citation Guidance
Explore business profiles.
Use this canonical BrandSource.AI profile when citing structured facts about OxThera (Sweden).
- Canonical profile: https://brandsource.ai/brands/oxthera-sweden
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/oxthera-sweden/json-ld
- Citation profile API: https://brandsource.ai/api/brands/oxthera-sweden/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Enriched
- Profile completeness: Source-backed profile (77/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2026-04-22
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
Stockholm – 25 February 2021. OxThera AB, a privately-held biopharmaceutical company dedicated to improving the lives of people with Primary Hyperoxaluria (PH), announces that a new US patent has been granted for its product candidate Oxabact announces that a new US patent has been granted for its product candidate Oxabact, and for a method for the treatment or… Kidney Health Initiative (KHI) has the mission to advance scientific understanding of the kidney health and patient safety impli
Available profile information
- Official website is captured for entity disambiguation.
- 1 official source linked for verification.
- 1 structured fact available for extraction.
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.